Recent developments in the chemotherapeutic options for nonsmall cell lung cancerIBRAHIM, M. Nazir; ABDULLAH, Zarina; MARTIN, Michael J et al.Expert review of anticancer therapy. 2006, Vol 6, Num 10, pp 1397-1410, issn 1473-7140, 14 p.Article

First-and second-line therapy for advanced nonsmall cell lung cancerSCULIER, J-P; MORO-SIBILOT, D.The European respiratory journal. 2009, Vol 33, Num 4, pp 915-930, issn 0903-1936, 16 p.Article

Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohortSCOCCIANTI, Chiara; VESIN, Aurélien; MARTEL, Ghislaine et al.The European respiratory journal. 2012, Vol 40, Num 1, pp 177-184, issn 0903-1936, 8 p.Article

Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancerBERGHMANS, T; MEERT, A. P; MARTIN, B et al.The European respiratory journal. 2005, Vol 25, Num 2, pp 329-335, issn 0903-1936, 7 p.Article

EGCG Inhibits Transforming Growth Factor-β-Mediated Epithelial-to-Mesenchymal Transition via the Inhibition of Smad2 and Erkl/2 Signaling Pathways in Nonsmall Cell Lung Cancer CellsLIU, Liang-Chih; CHANG-YAOTSAO, Thomas; HSU, Shu-Rong et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 39, pp 9863-9873, issn 0021-8561, 11 p.Article

A possible role for dihydrodiol dehydrogenase in the formation of benzo[a]pyrene-DNA adducts in lung cancer cells and tumor tissuesCHENG, Ya-Wen; TSAI, Horng-Jyh; WU, Jeng-Yuan et al.Environmental and molecular mutagenesis (Print). 2007, Vol 48, Num 1, pp 14-21, issn 0893-6692, 8 p.Article

Validation of the Lymph Node Ratio as a Prognostic Factor in Patients With N1 Nonsmall Cell Lung CancerJONNALAGADDA, Sirisha; ARCINEGA, Jacqueline; SMITH, Cardinale et al.Cancer. 2011, Vol 117, Num 20, pp 4724-4731, issn 0008-543X, 8 p.Article

Diagnosis of multiple primary lung cancer: A systematic reviewXINYING XUE; YUXIA LIU; LEI PAN et al.Journal of international medical research. 2013, Vol 41, Num 6, pp 1779-1787, issn 0300-0605, 9 p.Article

Is Sex Associated With the Outcome of Patients Treated With Radiation for Nonsmall Cell Lung Cancer?MCGOVERN, Susan L; ZHONGXING LIAO; KARA BUCCI, M et al.Cancer. 2009, Vol 115, Num 14, pp 3233-3242, issn 0008-543X, 10 p.Conference Paper

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancerMOHAMED, Sherif; YASUFUKU, Kazuhiro; FUJISAWA, Takehiko et al.Cancer. 2007, Vol 109, Num 12, pp 2506-2514, issn 0008-543X, 9 p.Article

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3BORGET, I; CADRANEL, J; DANIEL, C et al.The European respiratory journal. 2012, Vol 39, Num 1, pp 172-179, issn 0903-1936, 8 p.Article

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerPELOSI, G; PASTORINO, U; BRESAOLA, E et al.British journal of cancer. 2003, Vol 88, Num 4, pp 537-547, issn 0007-0920, 11 p.Article

Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalSILVA, J; GARCIA, V; HERRERA, M et al.The European respiratory journal. 2011, Vol 37, Num 3, pp 617-623, issn 0903-1936, 7 p.Article

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalOHRI, C. M; SHIKOTRA, A; GREEN, R. H et al.The European respiratory journal. 2009, Vol 33, Num 1, pp 118-126, issn 0903-1936, 9 p.Article

Application of glycoproteomics for the discovery of biomarkers in lung cancerQING KAY LI; GABRIELSON, Edward; HUI ZHANG et al.Proteomics. Clinical applications (Print). 2012, Vol 6, Num 5-6, pp 244-256, issn 1862-8346, 13 p.Article

Nuclear survivin in pN2 nonsmall cell lung cancer : prognostic and clinical implicationsMOHAMED, S; YASUFUKU, K; EL-SHAHHAT, H et al.The European respiratory journal. 2009, Vol 33, Num 1, pp 127-133, issn 0903-1936, 7 p.Article

Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancerLIMING SHENG; MIN LUO; XIAOJIANG SUN et al.International journal of cancer (Print). 2013, Vol 133, Num 11, pp 2720-2725, issn 0020-7136, 6 p.Article

Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosisGOTTSCHLING, Sandra; JENSEN, Katrin; WARTH, Arne et al.The European respiratory journal. 2013, Vol 41, Num 3, pp 656-663, issn 0903-1936, 8 p.Article

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patientsKRISTIANSEN, G; SCHLÜNS, K; YONGWEI, Y et al.British journal of cancer. 2003, Vol 88, Num 2, pp 231-236, issn 0007-0920, 6 p.Article

Progress and applications of mouse models for human lung cancerDE SERANNO, S; MEUWISSEN, R.The European respiratory journal. 2010, Vol 35, Num 2, pp 426-443, issn 0903-1936, 18 p.Article

Unexpected long-term survival after low-dose palliative radiotherapy for nonsmall cell lung cancerMAC MANUS, Michael P; MATTHEWS, Jane P; WADA, Morikatsu et al.Cancer. 2006, Vol 106, Num 5, pp 1110-1116, issn 0008-543X, 7 p.Article

Choice of endogenous control for gene expression in nonsmall cell lung cancerLIU, D. W; CHEN, S. T; LIU, H. P et al.The European respiratory journal. 2005, Vol 26, Num 6, pp 1002-1008, issn 0903-1936, 7 p.Article

Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: Using the LCSS-Meso conceptual model for validationHOLLEN, Patricia J; GRALLA, Richard J; LIEPA, Astra M et al.Cancer. 2004, Vol 101, Num 3, pp 587-595, issn 0008-543X, 9 p.Article

Expressed wishes and incidence of euthanasia in advanced lung cancer patientsPARDON, Koen; DESCHEPPER, Reginald; VANDER STICHELE, Robert et al.The European respiratory journal. 2012, Vol 40, Num 4, pp 949-956, issn 0903-1936, 8 p.Article

Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancerMONTUENGA, L. M; PIO, R; FABBRI, L. M et al.The European respiratory journal. 2007, Vol 30, Num 4, issn 0903-1936, 608-610, 627-632 [9 p.]Article